Ovarian Cancer Recurrence: Antiangiogenesis delays Progression

被引:0
|
作者
Hasenburg, A. [1 ]
机构
[1] Univ Med Mainz, Klin & Poliklin Geburtshilfe & Frauengesundheit, Langenbeckstr 1, D-55131 Mainz, Germany
来源
GYNAKOLOGE | 2019年 / 52卷 / 09期
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:638 / 638
页数:1
相关论文
共 50 条
  • [2] The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence
    Wesley, Tamsin
    Berzins, Stuart
    Kannourakis, George
    Ahmed, Nuzhat
    CELL COMMUNICATION AND SIGNALING, 2021, 19 (01)
  • [3] The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence
    Tamsin Wesley
    Stuart Berzins
    George Kannourakis
    Nuzhat Ahmed
    Cell Communication and Signaling, 19
  • [4] Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity
    Huarte, Eduardo
    Cubillos-Ruiz, Juan R.
    Nesbeth, Yolanda C.
    Scarlett, Uciane K.
    Martinez, Diana G.
    Buckanovich, Ronald J.
    Benencia, Fabian
    Stan, Radu V.
    Keler, Tibor
    Sarobe, Pablo
    Sentman, Charles L.
    Conejo-Garcia, Jose R.
    CANCER RESEARCH, 2008, 68 (18) : 7684 - 7691
  • [5] Variations of gene expression continuously accumulated according to progression of ovarian cancer recurrence
    Yang, W.
    Kong, J.
    Kim, H. J.
    Cho, H.
    Kim, S.
    Shin, H.
    Lee, E.
    Chay, D. B.
    Kim, J. H.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 88 - 89
  • [6] Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer
    Pizer, ES
    Wood, FD
    Heine, HS
    Romantsev, FE
    Pasternack, GR
    Kuhajda, FP
    CANCER RESEARCH, 1996, 56 (06) : 1189 - 1193
  • [7] Is a Brief Online Booklet Sufficient to Reduce Fear of Cancer Recurrence or Progression in Women With Ovarian Cancer?
    Pradhan, Poorva
    Sharpe, Louise
    Butow, Phyllis N.
    Ben Smith, Allan
    Russell, Hayley
    FRONTIERS IN PSYCHOLOGY, 2021, 12
  • [8] Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression
    Zhongyu Wang
    Yake Huang
    Ling Long
    Li Zhou
    Yan Huang
    Lei Gan
    Aimin Pu
    Sufen Li
    Rongkai Xie
    Journal of Ovarian Research, 14
  • [9] Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression
    Wang, Zhongyu
    Huang, Yake
    Long, Ling
    Zhou, Li
    Huang, Yan
    Gan, Lei
    Pu, Aimin
    Li, Sufen
    Xie, Rongkai
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [10] ME-344 delays tumor kinetics in an ovarian cancer in vivo recurrence model.
    Alvero, Ayesha B.
    Sumi, Natalia
    Craveiro, Vinicius
    Joo, Won Duk
    Yang-Hartwich, Yang
    Mor, Gil
    CANCER RESEARCH, 2013, 73 (08)